When was Eventide Asset Management founded?

Eventide Asset Management was founded in 2008.

Where is Eventide Asset Management headquartered?

Eventide Asset Management is headquartered in Boston, MA.

What is Eventide Asset Management's total asset value?

Eventide Asset Management has around in total assets under management.

How many investments has Eventide Asset Management made?

Eventide Asset Management has made 50 investments.

What has Eventide Asset Management invested in?

Eventide Asset Management has made numerous investments in companies like BridgeBio Oncology Therapeutics , Beta Bionics , and Inventiva Pharma within the Drug Discovery and Therapeutic Devices industries.

What has Eventide Asset Management invested in recently?

Eventide Asset Management's latest investment was on 28-Feb-2025 in BridgeBio Oncology Therapeutics , a company within the Drug Discovery industry.

Eventide Asset Management investment portfolio

Eventide Asset Management Overview

Investor Type

Venture Capital

Status

Active

Professionals

20

Investments

50

Portfolio

13

Exits

33

Eventide Asset Management General Information

Company Description

Founded in 2008, Eventide Asset Management is a venture capital firm based in Boston, Massachusetts. The firm seeks to make value-based investments. This firm is a Registered Investment Adviser (RIA).

Business Details

Website

www.eventideinvestments.com

Year Founded

2008

Investor Status

Actively Seeking New Investments

Primary Investor Type

Venture Capital

Other Investor Types

Mutual Fund

Corporate Office

One International Place
Suite 4210
Boston, MA 02110
United States

+1 (877)



Eventide Asset Management Investments (50)

Company Name	Deal Date	Deal Type	Industry	Company Stage
BridgeBio Oncology Therapeutics	28-Feb-2025	PIPE	Drug Discovery	Clinical Trials - Phase 1
Beta Bionics	13-Nov-2024		Therapeutic Devices	Generating Revenue/Not Profitable
Inventiva Pharma	14-Oct-2024		Drug Discovery	Generating Revenue/Not Profitable
PreciseDx	21-Aug-2024		Laboratory Services (Healthcare)	Generating Revenue
Kestra Medical Technologies	15-Jul-2024		Therapeutic Devices	Generating Revenue/Not Profitable
Lexeo Therapeutics	13-Mar-2024		Biotechnology	Generating Revenue/Not Profitable
Freenome	15-Feb-2024		Decision/Risk Analysis	Clinical Trials - General
Sudo Biosciences	01-Jan-2024		Drug Discovery	Pre-Clinical Trials
VYNE Therapeutics	01-Nov-2023	PIPE	Drug Discovery	Generating Revenue/Not Profitable
Avalyn Pharma	22-Sep-2023	Later Stage VC	Drug Discovery	Clinical Trials - Phase 2

You’re viewing 10 of 50 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eventide Asset Management Exits (33)

Company Name	Exit Date	Exit Type
Kestra Medical Technologies	06-Mar-2025	IPO
Beta Bionics	30-Jan-2025
Arch Oncology	31-May-2024
Praxis (Drug Discovery)	29-Mar-2024
Metagenomi	09-Feb-2024
Korro Bio	03-Nov-2023
Lexeo Therapeutics	03-Nov-2023
DICE Therapeutics	09-Aug-2023
Turnstone Biologics	21-Jul-2023	IPO
Prometheus Biosciences	15-Apr-2023	Merger/Acquisition

You’re viewing 10 of 33 exits. Get the full list »

Eventide Asset Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.